메뉴 건너뛰기




Volumn 356, Issue 3, 2016, Pages 604-614

ASB14780, an orally active inhibitor of group IVA phospholipase A2, is a pharmacotherapeutic candidate for nonalcoholic fatty liver disease

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 (4 PHENOXYPHENYL) 3 (2 PHENYLETHYL) 1H INDOL 5 YL]PROPANOIC ACID 2 AMINO 2 (HYDROXYMETHYL)PROPANE 1,3 DIOL SALT; ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CD11B ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 1A2; CYTOCHROME P450 2E1; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A2 INHIBITOR; RANTES; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 3-(1-(4-PHENOXYPHENYL)-3-(2-PHENYLETHYL)-1H-INDOL-5-YL)PROPANOIC ACID; ENZYME INHIBITOR; INDOLE DERIVATIVE; PHOSPHOLIPASE A2 GROUP IV; PROPIONIC ACID DERIVATIVE;

EID: 84959010789     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.229906     Document Type: Article
Times cited : (30)

References (58)
  • 2
    • 85041823681 scopus 로고    scopus 로고
    • Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    • Angelico F, Burattin M, Alessandri C, Del Ben M, and Lirussi F (2007) Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database Syst Rev (1):CD005166.
    • (2007) Cochrane Database Syst Rev (1) , pp. CD005166
    • Angelico, F.1    Burattin, M.2    Alessandri, C.3    Del Ben, M.4    Lirussi, F.5
  • 3
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231.
    • (2002) N Engl J Med , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 4
    • 33750722500 scopus 로고    scopus 로고
    • A temporal study on the histopathological, biochemical and molecular responses of CCl(4)-induced hepatotoxicity in Cyp2e1-null mice
    • Avasarala S, Yang L, Sun Y, Leung AW, Chan WY, Cheung WT, and Lee SS (2006) A temporal study on the histopathological, biochemical and molecular responses of CCl(4)-induced hepatotoxicity in Cyp2e1-null mice. Toxicology 228:310-322.
    • (2006) Toxicology , vol.228 , pp. 310-322
    • Avasarala, S.1    Yang, L.2    Sun, Y.3    Leung, A.W.4    Chan, W.Y.5    Cheung, W.T.6    Lee, S.S.7
  • 7
    • 33745125943 scopus 로고    scopus 로고
    • Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation
    • Chang TK, Crespi CL, and Waxman DJ (2006) Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. Methods Mol Biol 320:127-131.
    • (2006) Methods Mol Biol , vol.320 , pp. 127-131
    • Chang, T.K.1    Crespi, C.L.2    Waxman, D.J.3
  • 8
    • 33747517955 scopus 로고    scopus 로고
    • The epidemiology of nonalcoholic fatty liver disease in adults
    • Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40 (Suppl 1):S5-S10.
    • (2006) J Clin Gastroenterol , vol.40 , pp. S5-S10
    • Clark, J.M.1
  • 9
    • 77957961658 scopus 로고    scopus 로고
    • Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis
    • Cole LK, Jacobs RL, and Vance DE (2010) Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis. Hepatology 52: 1258-1265.
    • (2010) Hepatology , vol.52 , pp. 1258-1265
    • Cole, L.K.1    Jacobs, R.L.2    Vance, D.E.3
  • 10
    • 0037075831 scopus 로고    scopus 로고
    • Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton
    • Connolly S, Bennion C, Botterell S, Croshaw PJ, Hallam C, Hardy K, Hartopp P, Jackson CG, King SJ, and Lawrence L, et al. (2002) Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton. J Med Chem 45:1348-1362.
    • (2002) J Med Chem , vol.45 , pp. 1348-1362
    • Connolly, S.1    Bennion, C.2    Botterell, S.3    Croshaw, P.J.4    Hallam, C.5    Hardy, K.6    Hartopp, P.7    Jackson, C.G.8    King, S.J.9    Lawrence, L.10
  • 11
    • 1642285767 scopus 로고    scopus 로고
    • Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
    • Czaja AJ and Carpenter HA (2004) Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40:646-652.
    • (2004) J Hepatol , vol.40 , pp. 646-652
    • Czaja, A.J.1    Carpenter, H.A.2
  • 12
    • 33750038908 scopus 로고    scopus 로고
    • Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils
    • Flamand N, Picard S, Lemieux L, Pouliot M, Bourgoin SG, and Borgeat P (2006) Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils. Br J Pharmacol 149:385-392.
    • (2006) Br J Pharmacol , vol.149 , pp. 385-392
    • Flamand, N.1    Picard, S.2    Lemieux, L.3    Pouliot, M.4    Bourgoin, S.G.5    Borgeat, P.6
  • 13
    • 70449158340 scopus 로고
    • A simple method for the isolation and purification of total lipides from animal tissues
    • Folch J, Lees M, and Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
    • (1957) J Biol Chem , vol.226 , pp. 497-509
    • Folch, J.1    Lees, M.2    Sloane Stanley, G.H.3
  • 14
    • 41649107806 scopus 로고    scopus 로고
    • 1-(2-Carboxyindol-5-yloxy) propan-2-ones as inhibitors of human cytosolic phospholipase A2a: Synthesis, biological activity, metabolic stability, and solubility
    • Fritsche A, Elfringhoff AS, Fabian J, and Lehr M (2008) 1-(2-Carboxyindol-5-yloxy) propan-2-ones as inhibitors of human cytosolic phospholipase A2a: synthesis, biological activity, metabolic stability, and solubility. Bioorg Med Chem 16: 3489-3500.
    • (2008) Bioorg Med Chem , vol.16 , pp. 3489-3500
    • Fritsche, A.1    Elfringhoff, A.S.2    Fabian, J.3    Lehr, M.4
  • 15
    • 33845593130 scopus 로고    scopus 로고
    • Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver
    • Gudbrandsen OA, Rost TH, and Berge RK (2006) Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver. J Lipid Res 47: 2223-2232.
    • (2006) J Lipid Res , vol.47 , pp. 2223-2232
    • Gudbrandsen, O.A.1    Rost, T.H.2    Berge, R.K.3
  • 16
    • 33947111963 scopus 로고    scopus 로고
    • 1-(5-Carboxy-and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2a: Bioisosteric replacement of the carboxylic acid and carboxamide moiety
    • Hess M, Schulze Elfringhoff A, and Lehr M (2007) 1-(5-Carboxy-and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2a: bioisosteric replacement of the carboxylic acid and carboxamide moiety. Bioorg Med Chem 15:2883-2891.
    • (2007) Bioorg Med Chem , vol.15 , pp. 2883-2891
    • Hess, M.1    Schulze Elfringhoff, A.2    Lehr, M.3
  • 19
    • 0026556949 scopus 로고
    • Free fatty acid transfer from rat liver fatty acid-binding protein to phospholipid vesicles
    • Kim HK and Storch J (1992) Free fatty acid transfer from rat liver fatty acid-binding protein to phospholipid vesicles. Effect of ligand and solution properties. J Biol Chem 267:77-82.
    • (1992) Effect of Ligand and Solution Properties. J Biol Chem , vol.267 , pp. 77-82
    • Kim, H.K.1    Storch, J.2
  • 20
    • 33750964517 scopus 로고    scopus 로고
    • Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s
    • Kita Y, Ohto T, Uozumi N, and Shimizu T (2006) Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochim Biophys Acta 1761: 1317-1322.
    • (2006) Biochim Biophys Acta , vol.1761 , pp. 1317-1322
    • Kita, Y.1    Ohto, T.2    Uozumi, N.3    Shimizu, T.4
  • 25
    • 34648832073 scopus 로고    scopus 로고
    • Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: A meta-analysis of randomised clinical trials
    • Lago RM, Singh PP, and Nesto RW (2007) Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370:1129-1136.
    • (2007) Lancet , vol.370 , pp. 1129-1136
    • Lago, R.M.1    Singh, P.P.2    Nesto, R.W.3
  • 26
    • 77958113232 scopus 로고    scopus 로고
    • Bone loss in diabetes: Use of antidiabetic thiazolidinediones and secondary osteoporosis
    • Lecka-Czernik B (2010) Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep 8:178-184.
    • (2010) Curr Osteoporos Rep , vol.8 , pp. 178-184
    • Lecka-Czernik, B.1
  • 28
    • 78650509559 scopus 로고    scopus 로고
    • Gene expression profiling of murine hepatic steatosis induced by tamoxifen
    • Lee MH, Kim JW, Kim JH, Kang KS, Kong G, and Lee MO (2010) Gene expression profiling of murine hepatic steatosis induced by tamoxifen. Toxicol Lett 199: 416-424.
    • (2010) Toxicol Lett , vol.199 , pp. 416-424
    • Lee, M.H.1    Kim, J.W.2    Kim, J.H.3    Kang, K.S.4    Kong, G.5    Lee, M.O.6
  • 29
    • 21744460524 scopus 로고    scopus 로고
    • Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis
    • Lelliott CJ, Lápez M, Curtis RK, Parker N, Laudes M, Yeo G, Jimenez-Liñan M, Grosse J, Saha AK, and Wiggins D, et al. (2005) Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis. FASEB J 19:1108-1119.
    • (2005) FASEB J , vol.19 , pp. 1108-1119
    • Lelliott, C.J.1    Lápez, M.2    Curtis, R.K.3    Parker, N.4    Laudes, M.5    Yeo, G.6    Jimenez-Liñan, M.7    Grosse, J.8    Saha, A.K.9    Wiggins, D.10
  • 30
    • 81355149613 scopus 로고    scopus 로고
    • Cytosolic phospholipase A(2)a protects against Fas-but not LPS-induced liver injury
    • Li G, Chen W, Han C, and Wu T (2011) Cytosolic phospholipase A(2)a protects against Fas-but not LPS-induced liver injury. J Hepatol 55:1281-1290.
    • (2011) J Hepatol , vol.55 , pp. 1281-1290
    • Li, G.1    Chen, W.2    Han, C.3    Wu, T.4
  • 32
    • 33646146486 scopus 로고    scopus 로고
    • Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2a
    • Ludwig J, Bovens S, Brauch C, Elfringhoff AS, and Lehr M (2006) Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2a. J Med Chem 49:2611-2620.
    • (2006) J Med Chem , vol.49 , pp. 2611-2620
    • Ludwig, J.1    Bovens, S.2    Brauch, C.3    Elfringhoff, A.S.4    Lehr, M.5
  • 33
    • 0036154816 scopus 로고    scopus 로고
    • NASH: From liver diseases to metabolic disorders and back to clinical hepatology
    • Marchesini G and Forlani G (2002) NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 35:497-499.
    • (2002) Hepatology , vol.35 , pp. 497-499
    • Marchesini, G.1    Forlani, G.2
  • 35
    • 0031043030 scopus 로고    scopus 로고
    • The mitochondrial carnitine palmitoyltransferase system. from concept to molecular analysis
    • McGarry JD and Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14.
    • (1997) Eur J Biochem , vol.244 , pp. 1-14
    • McGarry, J.D.1    Brown, N.F.2
  • 37
    • 45749141743 scopus 로고    scopus 로고
    • Indole cytosolic phospholipase A2 a inhibitors: Discovery and in vitro and in vivo characterization of 4-3-[5-chloro-2-(2-[(3,4-dichlorobenzyl)sulfonyl]aminoethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propylbenzoic acid, efipladib
    • McKew JC, Lee KL, Shen MW, Thakker P, Foley MA, Behnke ML, Hu B, Sum FW, Tam S, and Hu Y, et al. (2008) Indole cytosolic phospholipase A2 a inhibitors: discovery and in vitro and in vivo characterization of 4-3-[5-chloro-2-(2-[(3,4-dichlorobenzyl)sulfonyl]aminoethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propylbenzoic acid, efipladib. J Med Chem51:3388-3413.
    • (2008) J Med Chem , vol.51 , pp. 3388-3413
    • McKew, J.C.1    Lee, K.L.2    Shen, M.W.3    Thakker, P.4    Foley, M.A.5    Behnke, M.L.6    Hu, B.7    Sum, F.W.8    Tam, S.9    Hu, Y.10
  • 39
    • 77954239704 scopus 로고    scopus 로고
    • A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
    • Musso G, Gambino R, Cassader M, and Pagano G (2010) A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 52: 79-104.
    • (2010) Hepatology , vol.52 , pp. 79-104
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 40
    • 0019948222 scopus 로고
    • Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical
    • Noguchi T, Fong KL, Lai EK, Alexander SS, King MM, Olson L, Poyer JL, and McCay PB (1982) Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical. Biochem Pharmacol 31: 615-624.
    • (1982) Biochem Pharmacol , vol.31 , pp. 615-624
    • Noguchi, T.1    Fong, K.L.2    Lai, E.K.3    Alexander, S.S.4    King, M.M.5    Olson, L.6    Poyer, J.L.7    McCay, P.B.8
  • 41
    • 0036566182 scopus 로고    scopus 로고
    • Characterization of a novel inhibitor of cytosolic phospholipase A2a, pyrrophenone
    • Ono T, Yamada K, Chikazawa Y, Ueno M, Nakamoto S, Okuno T, and Seno K (2002) Characterization of a novel inhibitor of cytosolic phospholipase A2a, pyrrophenone. Biochem J 363:727-735.
    • (2002) Biochem J , vol.363 , pp. 727-735
    • Ono, T.1    Yamada, K.2    Chikazawa, Y.3    Ueno, M.4    Nakamoto, S.5    Okuno, T.6    Seno, K.7
  • 43
    • 0037105253 scopus 로고    scopus 로고
    • Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in D-galactosamine (D-GalN)-sensitized mice
    • Osakabe N, Yasuda A, Natsume M, Sanbongi C, Kato Y, Osawa T, and Yoshikawa T (2002) Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in D-galactosamine (D-GalN)-sensitized mice. Free Radic Biol Med 33:798-806.
    • (2002) Free Radic Biol Med , vol.33 , pp. 798-806
    • Osakabe, N.1    Yasuda, A.2    Natsume, M.3    Sanbongi, C.4    Kato, Y.5    Osawa, T.6    Yoshikawa, T.7
  • 44
    • 80051975559 scopus 로고    scopus 로고
    • Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting
    • Piccinni C, Motola D, Marchesini G, and Poluzzi E (2011) Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting. Diabetes Care 34:1369-1371.
    • (2011) Diabetes Care , vol.34 , pp. 1369-1371
    • Piccinni, C.1    Motola, D.2    Marchesini, G.3    Poluzzi, E.4
  • 45
    • 4444289142 scopus 로고    scopus 로고
    • Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes
    • Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, and Friedman SL (2004) Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127:870-882.
    • (2004) Gastroenterology , vol.127 , pp. 870-882
    • Safadi, R.1    Ohta, M.2    Alvarez, C.E.3    Fiel, M.I.4    Bansal, M.5    Mehal, W.Z.6    Friedman, S.L.7
  • 48
    • 0035952312 scopus 로고    scopus 로고
    • Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: Synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'
    • Seno K, Okuno T, Nishi K, Murakami Y, Yamada K, Nakamoto S, and Ono T (2001) Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. Bioorg Med Chem Lett 11:587-590.
    • (2001) Bioorg Med Chem Lett , vol.11 , pp. 587-590
    • Seno, K.1    Okuno, T.2    Nishi, K.3    Murakami, Y.4    Yamada, K.5    Nakamoto, S.6    Ono, T.7
  • 51
    • 84899764290 scopus 로고    scopus 로고
    • Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)
    • Takaki A, Kawai D, and Yamamoto K (2014) Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci 15: 7352-7379.
    • (2014) Int J Mol Sci , vol.15 , pp. 7352-7379
    • Takaki, A.1    Kawai, D.2    Yamamoto, K.3
  • 52
    • 77952565420 scopus 로고    scopus 로고
    • The role of cytokines in non-alcoholic fatty liver disease
    • Tilg H (2010) The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 28: 179-185.
    • (2010) Dig Dis , vol.28 , pp. 179-185
    • Tilg, H.1
  • 53
    • 78049522194 scopus 로고    scopus 로고
    • Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
    • Tilg H and Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836-1846.
    • (2010) Hepatology , vol.52 , pp. 1836-1846
    • Tilg, H.1    Moschen, A.R.2
  • 54
    • 1942470397 scopus 로고    scopus 로고
    • Review article: Current management of alcoholic liver disease
    • Tome S and Lucey MR (2004) Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther 19:707-714.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 707-714
    • Tome, S.1    Lucey, M.R.2
  • 55
    • 84921457246 scopus 로고    scopus 로고
    • Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2a inhibitors
    • Tomoo T, Nakatsuka T, Katayama T, Hayashi Y, Fujieda Y, Terakawa M, and Nagahira K (2014) Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2a inhibitors. J Med Chem 57:7244-7262.
    • (2014) J Med Chem , vol.57 , pp. 7244-7262
    • Tomoo, T.1    Nakatsuka, T.2    Katayama, T.3    Hayashi, Y.4    Fujieda, Y.5    Terakawa, M.6    Nagahira, K.7
  • 56
    • 0029144666 scopus 로고
    • Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis
    • Tsukamoto H, Rippe R, Niemelä O, and Lin M (1995) Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 10 (Suppl 1):S50-S53.
    • (1995) J Gastroenterol Hepatol , vol.10 , pp. S50-S53
    • Tsukamoto, H.1    Rippe, R.2    Niemelä, O.3    Lin, M.4
  • 58
    • 0023785310 scopus 로고
    • Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver
    • Zerbe O and Gressner AM (1988) Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol 49: 87-101.
    • (1988) Exp Mol Pathol , vol.49 , pp. 87-101
    • Zerbe, O.1    Gressner, A.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.